Table of Contents

company-logo

Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops Ubiquitin-specific protease 1, an inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. Tango Therapeutics, Inc. has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. The company was founded in 2017 and is based in Cambridge, Massachusetts.

Tango Therapeutics Dividend Announcement

• Tango Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Tango Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Tango Therapeutics Dividend History

Tango Therapeutics Dividend Yield

Tango Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Tango Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Tango Therapeutics Financial Ratios

P/E ratio-3.13
PEG ratio0.03
P/B ratio1.69
ROE-49.64%
Payout ratio0.00%
Current ratio8.00
Quick ratio8.00
Cash Ratio1.41

Tango Therapeutics Dividend FAQ

Does Tango Therapeutics stock pay dividends?
Tango Therapeutics does not currently pay dividends to its shareholders.
Has Tango Therapeutics ever paid a dividend?
No, Tango Therapeutics has no a history of paying dividends to its shareholders. Tango Therapeutics is not known for its dividend payments.
Why doesn't Tango Therapeutics pay dividends?
There are several potential reasons why Tango Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Tango Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Tango Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Tango Therapeutics a dividend aristocrat?
Tango Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Tango Therapeutics a dividend king?
Tango Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Tango Therapeutics a dividend stock?
No, Tango Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Tango Therapeutics stocks?
To buy Tango Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Tango Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.